ataxin 3
Zuletzt aktualisiert 18. Aug 2020
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The ATXN3 gene provides instructions for making an enzyme called ataxin-3, which is found in cells throughout the body. Ataxin-3 is involved in a mechanism called the ubiquitin-proteasome system that destroys and gets rid of excess or damaged proteins. The molecule ubiquitin attaches (binds) to unneeded proteins and tags them to be broken down (degraded) within cells. Ataxin-3 removes (cleaves) the ubiquitin from these unwanted proteins just before they are degraded so that the ubiquitin can be used again. Due to its role in cleaving ubiquitin from proteins, ataxin-3 is known as a deubiquitinating enzyme.
Normal function
The ATXN3 gene provides instructions for making an enzyme called ataxin-3, which is found in cells throughout the body. Ataxin-3 is involved in a mechanism called the ubiquitin-proteasome system that destroys and gets rid of excess or damaged proteins. The molecule ubiquitin attaches (binds) to unneeded proteins and tags them to be broken down (degraded) within cells. Ataxin-3 removes (cleaves) the ubiquitin from these unwanted proteins just before they are degraded so that the ubiquitin can be used again. Due to its role in cleaving ubiquitin from proteins, ataxin-3 is known as a deubiquitinating enzyme.
Researchers believe that ataxin-3 also may be involved in regulating the first stage of protein production (transcription).
Conditions referring to this gene or chromosome
Other names
AT3
ataxin-3
ATX3
ATX3_HUMAN
Related patient information and medicines

Patient information leaflet
Lyme-Borreliose
Lyme-Borreliose ist ein Infektion caused by being bitten by an infected tick. The first and most common symptom is a rash that spreads out from the site of the tick bite. Left untreated, the germs (bacteria) can spread to other areas of the body. In some cases this can cause serious symptoms - often months after the initial tick bite. A course of.

Patient information leaflet
Brustschmerzen
Most women develop breast pain (mastalgia) at some stage in life. In most cases the pain develops in the days just before a period. If needed, treatment options include pain reliever and rub-on (topical) anti-inflammatory drugs Topical anti-inflammatory painkillers. Take regularly on the days when the breasts are painfulRub-on (topical).

Patient information leaflet
Impfung gegen Grippe
If 10 people have the flu jab, it usually provides protection from flu for 7 or 8 of them. If the vaccine does not match the predicted flu types around that year, the protection rate can be lower. For example, in 2025-2026 the predictions by the scientists were less good than usual and the vaccine only protected between 2 and 3.4 in 10 adults and.

Patient information leaflet
Masern
Diarrhoea Diarrhoea and/or. A red blotchy rash normally develops about 3-4 days after the first symptoms. It usually starts on the head and neck and spreads down the body. This is called 'post-exposure prophylaxis'. See the guidelines from the UK Health Security Agency (UKHSA) cited at the end under 'Further Reading and References'. How do you.

Patient information leaflet
Fingerspitzen-Einheiten für topische Steroide
Topical steroids are used for various skin conditions. The amount of topical steroid that you should apply is commonly measured by fingertip units. Topical steroids are creams, ointments and lotions which contain steroid drugs. Topical steroids work by reducing inflammation in the skin. They are used for various skin conditions, such as atopic.

Patient information leaflet
Polio und Polio-Impfstoff
Polio (poliomyelitis), is a serious illness that can be debilitating and life-threatening. Polio (poliomyelitis) is a serious illness caused by a virus called poliovirus. ServiceUpsellPlaceholder PatientPicksPlaceholder The UK vaccine programme For young children , polio vaccine is normally part of the combined DTaP/IPV(polio)/Hib/Hep B injection.
Weiterführende Lektüre und Referenzen
- ataxin 3; MedlinePlus, National Library of Medicine.
- D'Abreu A, Franca MC Jr, Paulson HL, Lopes-Cendes I. Caring for Machado-Joseph disease: current understanding and how to help patients. Parkinsonism Relat Disord. 2010 Jan;16(1):2-7. doi: 10.1016/j.parkreldis.2009.08.012. Epub 2009 Oct 6.
- Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum Mol Genet. 2006 Feb 15;15(4):555-68. doi: 10.1093/hmg/ddi472. Epub 2006 Jan 11.
- Nicastro G, Masino L, Esposito V, Menon RP, De Simone A, Fraternali F, Pastore A. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites. Biopolymers. 2009 Dec;91(12):1203-14. doi: 10.1002/bip.21210.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
18. Aug 2020 | Neueste Version
1 Feb 2011 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

